Trade Summary

5 days ago, Leiden Jeffrey M, serving as Dir at Odyssey Therapeutics, Inc. (ODTX), purchased 5,000 shares at $20.00 per share, for a total transaction value of $100,000.00. Following this transaction, Leiden Jeffrey M now holds 301,842 shares of ODTX.

This purchase represents a 2.00% increase in Leiden Jeffrey M's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 8, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 11, 2026, 3 days after the trade was made.

Odyssey Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.